Ironwood Pharmaceuticals

Pharmaceuticals & Biotech

Ironwood Pharmaceuticals Careers, Pay and Expert Network

lightbulbWhat are the highest paying jobs at Ironwood Pharmaceuticals?

Ironwood Pharmaceuticals, Inc is a drug manufacturer that develops and markets medicines of different types. One of its main products, Linaclotide, is drug approved by the U.S. Food and Drug Administration (FDA) and marketed since December 2012. In February 2014, the company was approved allowance by the United States Patent and Trademark Office (USPTO) to apply a patent on Linzess and will be protect through 2031. The company is publicly listed on NASDAQ with the symbol "IRWD". In 2008, Microbia, Inc. changed its name to Ironwood Pharmaceuticals, Inc. This principal product of Ironwood Pharmaceuticals was approved by the US FDA in August 2012, and reached the US market in December 2012. The drug is focused on treating irritable bowel syndrome and related symptoms, which according to the National Institutes of Health (NIH) affects around 20% of Americans. Linaclotide is estimated to reach blockbuster status in around the year 2021, based on the forecast of market research firm Decision Resources.


Market Cap$1.7 billion
Revenue$363.3 million
5 Year Trend+28.6%
Net Income-$47.7 million
Annual Report
Total value of jobs:
Total Jobs:
Average Pay:
Total Experts:
% Masters:

Top Experts at Ironwood Pharmaceuticals

Ironwood Pharmaceuticals Salaries

Marketing Director



Average Salary:$225,000

Quality Control Manager



Average Salary:$125,000

View All Salaries